Overview

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

To determine the efficacy of intravitreal ranibizumab injection as adjuvant therapy in the treatment of postvitrectomy diabetic vitreous hemorrhage (PDVH) accompanied by neovascular glaucoma (NVG) as a means of preventing recurrent vitreous hemorrhage （VH） and optimizing postoperative intraocular pressure（IOP）control.

Phase:

Phase 4

Details

Lead Sponsor:

Ruijin Hospital

Collaborator:

Ningbo University

Treatments:

Ranibizumab